← Chaos Factor

Do Drug Users Come in Types?

Loosely. Among 3,442 people, nearly everyone had tried marijuana and most had tried mushrooms or LSD; rarer drugs turn up mainly in long lists. Across 11,445 ratings of 17 drugs, experiences fall into five loose types, and each drug has its own mix. Panic and regret go more with the person than with the drug, though most of the variation goes with neither. And a strongest experience of 5 out of 5 ranges from about half of salvia and DMT users, and a third of drinkers (almost all of them heavy drinkers), to 3 or 4% of MDMA, ecstasy, MDA and 2C-B users.

Drug Experiences Survey · November 2026 · drug lists from 3,442 people, 11,445 drug ratings from 3,430 · companion to The Drug Report Card

The Drug Experiences survey (October 2024 to January 2025) asked people which of 47 drugs they had ever done, then asked the same 31 questions about each one. The Drug Report Card ranked the drugs; this page looks for types. The checklists, "Which of the following drugs have you done?" and "Now for some more uncommon ones. Have you done any of the following?", cover marijuana, alcohol, psychedelics, MDMA and ecstasy, dissociatives, GHB, kratom and many research chemicals, but not cocaine, amphetamines, opioids or benzodiazepines.

Short version

  1. Drug lists nest loosely. 94% of people who had tried any listed drug had tried marijuana, and 89% psilocybin or LSD; rarer drugs turn up mainly in long lists (people who had tried DMT had tried a median of 10 listed drugs, against 5 for everyone). The survey asked only whether people had ever done each drug, not when, so this isn't an order of use.
  2. Five loose portfolio types, mostly reflecting how many drugs people have tried. They run from marijuana and mushrooms (39%) to nearly everything (4%), with a split in the middle between club drugs (26%) and DMT, salvia, kratom or DXM (14%). Younger people have tried fewer drugs, which explains most of the age gap: 58% of 18 to 24-year-olds are in the first type, against 30 to 35% of 25 to 54-year-olds (58% against 47 to 49% among people who have tried three to six drugs).
  3. Experiences come in five loose types, and each drug has its own mix. 60% of ayahuasca ratings are deep, 59% of MDMA ratings fun, 49% of nitrous ratings intense but not deep, and 40% of salvia and of DXM ratings rough; DMT splits between deep (40%) and intense but not deep (37%).
  4. Panic and regret go more with the person than with the drug, though most of the variation goes with neither. Who was answering goes with 17 to 18% of the variation in panic and regret, which drug it was with 8 to 11%, and neither with 72 to 75%. People who panicked on more than half their trips with one drug panicked on 28% of trips with their other drugs, against 13% for people who never panicked on it.
  5. The same kinds of people report more panic across drugs; few drug-specific matches were detectable. People who agree "I worry about things." report panic on 18% of their trips, against 13% for those who disagree. Of 1,300 combinations of a trait and a drug, 9 passed a strict test with little power for less common drugs; one is that people with PTSD or C-PTSD would take back more of their uses of other drugs (19% against 14%) but not of marijuana (26% against 28%).
  6. How rare is a 5 out of 5? About half of salvia and DMT users put their strongest experience at 5, "no connection to reality, completely unaware of what's happening", against 12 to 13% for psilocybin and LSD and 3 to 4% for MDMA, ecstasy, MDA and 2C-B. It rises steeply with use, and alcohol's 31% comes from heavy drinkers (10% among those who have drunk 50 times or fewer). Of people who rated every drug they had tried, 33% have had a 5 on a drug other than alcohol.
  1. Which drugs go together
  2. Five portfolio types
  3. Five kinds of experience
  4. Is it you or the drug?
  5. Who does better on what
  6. Ways of relating to drugs
  7. How intense does it get?
  8. Could it be something else?
  9. Methods and limits

1. Which drugs go together

3,442 people answered both checklists and had tried at least one listed drug other than alcohol, which was added to the checklist a few days into the run. They're 71% cis men, 17% cis women and 12% trans or nonbinary, aged 14 to 81 (median 32); 68% lean left and 72% came from Twitter. They had tried a median of 5 of the 46 listed drugs (mean 6.3): 94% marijuana, 81% psilocybin, 71% LSD, 56% MDMA, 48% ecstasy, 42% ketamine, 39% nitrous oxide, and about a quarter each DMT and 2C-B. 84% had tried marijuana and at least one of psilocybin and LSD.

Heatmap of the share who have tried each of 16 drugs, by how many of the listed drugs people have tried. With one drug: marijuana 73%, psilocybin 14%. With two: marijuana 91%, psilocybin 58%, LSD 20%. With three: LSD 53%. MDMA reaches 42% at four drugs and 56% at five, ketamine 66% at seven or eight, nitrous 59% at seven or eight, DMT 52% and 2C-B 53% at nine to eleven, and 5-MeO-DMT, GHB, mescaline, DXM, salvia and kratom reach about half only among people who have tried twelve or more.
Figure 1. Share of people who have tried each drug, by how many of the 46 listed drugs (alcohol not counted) they have tried. Number of people in each column in brackets. 3,442 people.

The longer someone's list, the more predictable what's on it, but only loosely. People who had tried one listed drug had mostly tried marijuana (73%) or psilocybin (14%); with two, the usual pair was marijuana and psilocybin (52%) or marijuana and LSD (16%). MDMA and ecstasy become common in lists of four to six drugs, ketamine and nitrous at seven or eight, DMT and 2C-B at around ten, and 5-MeO-DMT, GHB, mescaline, DXM, salvia and kratom mostly at twelve or more.

The nesting is loose. Among the 2,832 people who had tried two to seven of the eight most common drugs, 36% had exactly the most common ones for their count (someone with three had marijuana, psilocybin and LSD; someone with four added MDMA, and so on), against 18% expected if people picked drugs independently. Loevinger's H, a standard measure of how well items form one cumulative scale, is 0.41, a moderate scale. Since the survey asked only whether people had ever done each drug, none of this describes an order in which people took them.

2. Five portfolio types

A latent class model sorts people into groups whose members tend to have tried the same drugs. Fitted to the 25 drugs tried by at least 2% of people, it finds five types:

Heatmap of the share of each of five portfolio types who have tried each of 21 drugs. Marijuana and mushrooms (39%): marijuana 91, psilocybin 62, LSD 40, MDMA 16. Psychedelics and club drugs (26%): psilocybin 86, LSD 84, MDMA 86, ecstasy 76, ketamine 57, DMT 13, DXM 2. Psychedelics, few club drugs (14%): psilocybin 93, LSD 88, MDMA 42, ecstasy 35, DMT 39, kratom 38, salvia 34, DXM 25. Wide explorers (18%): MDMA 97, ketamine 87, DMT 64, 2C-B 59. Nearly everything (4%): most drugs above 50%, including 2C-I 56 and 2C-E 55.
Figure 2. Share of each type who have tried each drug (21 of the 25 drugs in the model shown). Type shares are the average of each person's probability of belonging to each type; 12% of people have no type with a probability above 60%. 3,442 people.

Most of the difference between types is how many drugs people have tried, with one split in the middle. At around six drugs, people divide between club drugs (MDMA, ecstasy, ketamine, 2C-B) and DMT, salvia, kratom and DXM. The boundaries are fuzzy, and many people sit between two types.

Because the types track list length, they also track age: younger people have tried fewer drugs (4.5 on average at 18 to 24, against 7.2 to 7.3 at 35 to 54). 58% of 18 to 24-year-olds are in the marijuana-and-mushrooms type, against 30 to 35% of 25 to 54-year-olds and 48% of people 55 and over (and 81% of the 36 people aged 14 to 17). List length explains most of that gap but not all: among people who had tried three to six drugs, it shrinks to 58% against 47 to 49%, so about 10 points remain. Sex makes a few points' difference: 30% of cis women are in the psychedelics-and-club-drugs type against 26% of cis men (5 points after age adjustment). Politics and education make almost none.

3. Five kinds of experience

For each drug, people answered 26 questions about how it went: typical and strongest intensity; what share of their trips were "significantly pleasurable", or involved "paranoia, panic attacks, or acute anxiety", "delusions" or "the sensation of contacting other beings"; what share of their uses they'd go back and stop; the drug's impact on six areas of life; and 13 agree-disagree statements. A factor analysis finds five dimensions:

DimensionAnswers that make it upHighestLowest
Helped my lifePositive impact on motivation, life, cognition and empathy; helped heal trauma; creativity; sexualityAyahuasca, psilocybin, LSDAlcohol, nitrous oxide, DXM
SpiritualMore belief in "spirits, higher dimensional beings, or aliens"; "made me more spiritual"; contact with beings; "permanently changed concrete, testable beliefs"Ayahuasca, 5-MeO-DMT, DMTGHB, alcohol, nitrous oxide
Fun and functionalGood "while partying", "to enhance sex", "while doing things that require physical skill" and, more weakly, "while at work"MDMA, ecstasy, MDASalvia, ayahuasca, DMT
RoughMore trips with panic or acute anxiety; more uses they'd take back; fewer pleasurable tripsSalvia, DXM, marijuanaMDMA, ecstasy, MDA
IntenseTypical intensity; strongest experienceDMT, 5-MeO-DMT, salvia2C-B, MDA, MDMA

Highest and lowest are among the 17 drugs with 100 or more raters, on each drug's average score.

Sorting each rating by its scores on these dimensions gives five loose types of experience. Deep: very high on spiritual, high on helped my life, intense. Fun: high on fun and functional, somewhat high on helped my life, low on rough. Intense, not deep: intense, slightly below average on everything else. Mild: below average on everything, especially intensity. Rough: high on rough, low on helped my life and fun. Most ratings sit between types rather than in tight clusters.

Heatmap of the share of each drug's ratings in each of five experience types. Ayahuasca: deep 60, intense not deep 21. DMT: deep 40, intense not deep 37. 5-MeO-DMT: deep 39, intense not deep 35. Psilocybin: deep 29, fun 15, intense 21, mild 26, rough 9. LSD: deep 24, fun 20, intense 24, mild 21, rough 11. MDMA: fun 59, mild 23. Ecstasy: fun 51, mild 28. MDA: fun 39, mild 34. Ketamine: intense not deep 39, mild 31. Nitrous oxide: intense not deep 49, mild 31. DXM: rough 40, intense 27, mild 26. Salvia: rough 40, intense 35. Marijuana: mild 32, fun 29, rough 25. Alcohol: mild 41, rough 25, intense 21. GHB: mild 44, fun 21. Mescaline: mild 39. 2C-B: mild 44, fun 30.
Figure 3. Share of each drug's ratings in each experience type; each row adds to 100. 10,034 ratings by 2,835 people with all five dimension scores. Each rating covers all the times someone took that drug. The types don't include "damaged my physical health".

Each drug has its own mix. Ayahuasca is the most often deep (60%). DMT and 5-MeO-DMT split between deep (40% and 39%) and intense but not deep (37% and 35%). MDMA (59%) and ecstasy (51%) are mostly fun; nitrous (49%) and ketamine (39%) most often intense but not deep. Salvia and DXM are the most often rough (40% each), then marijuana and alcohol (25% each). GHB, 2C-B, alcohol and mescaline are most often mild (39 to 44%). Psilocybin and LSD are the most even mix: for psilocybin, 29% deep, 26% mild, 21% intense but not deep, 15% fun and 9% rough.

"Mild" undersells alcohol. The types leave out "[drug] has damaged my physical health", and alcohol is far ahead on it: 26% of drinkers agree moderately or strongly, against 8% for marijuana and 6% or less for every other drug, and so do 15% of the alcohol ratings classed as mild. Alcohol is also the only drug whose average impact on life is negative (−0.40 on a −3 to +3 scale; 40% say it hurt their life, 22% that it helped).

A person's type on one drug says something about their type on another: among people who rated two or more drugs, a deep rating for one drug went with a deep rating for a second 28% of the time, against 11% expected from those drugs' usual mix, and rough went with rough 20% of the time, against 15%.

4. Is it you or the drug?

Many people rated several drugs, so the variation in each answer can be split three ways: differences between drugs, differences between people (some people report more panic, or more pleasure, on all their drugs), and what's left over, which is the particular pairing of person and drug plus noise in how people answered.

Dot plot of the share of variation going with which drug it was and with who was answering. Panic or acute anxiety: drug 8%, person 17%. Uses they'd go back and stop: drug 11%, person 18%. Delusions: drug 15%, person 19%. Strongest experience: drug 19%, person 17%. Impact on life: drug 17%, person 14%. Significantly pleasurable trips: drug 18%, person 10%. Contact with beings: drug 37%, person 15%. Typical intensity: drug 32%, person 11%.
Figure 4. Share of the variation in each answer that goes with which drug it was and with who was answering, from a model with a separate average for each drug and each person (17 drugs with 100 or more raters). Bars are 95% intervals from resampling people; they don't reflect that the drug share rests on only 17 drugs. Leaving out one drug at a time, the drug share ranges from 6 to 9% for panic, 9 to 12% for regret, 29 to 42% for contact with beings and 11 to 19% for pleasure. The drug share for contact with beings comes from DMT, ayahuasca, 5-MeO-DMT and, to a lesser degree, salvia; among the eight most common drugs the person matters more (28% against 9%).

Panic and regret go more with the person; contact with beings and typical intensity go more with the drug; most goes with neither. Who was answering goes with 17% of the variation in panic and 18% in regret, against 8% and 11% for which drug it was, and the person stays ahead whichever drug is left out. Contact with beings goes with the drug more than any other answer (37% drug, 15% person), then typical intensity (32% and 11%). Pleasure seems to go with the drug (18% against 10%) only because of salvia: without it, person and drug tie at 11%. For strongest experience and impact on life the two are about even. In every case the largest part, 48 to 75%, goes with neither. Put another way, for any two drugs rated by the same person, each compared with that drug's average, answers correlate 0.19 for panic and regret, 0.22 for delusions and 0.12 for pleasure.

Three line charts. Panic: people with no panic on one drug panicked on 13% of trips with their other drugs; 1-10%: 15%; 11-25%: 18%; 26-50%: 24%; over 50%: 28%; the average for those other drugs is about 17%. Uses they'd go back and stop: 15%, 16%, 19%, 24% and 27%, against an average of about 17 to 18%. Significantly pleasurable: people with 50% or fewer pleasurable trips on one drug had 67% pleasurable trips on their other drugs, rising to 76% for 91-99% and 74% for 100%, against an average of about 71%.
Figure 5. Average answer for a person's other drugs, by their answer for one drug. Every drug a person rated takes a turn as "one drug", and each person counts equally. Dashed line: the average for those same other drugs among everyone who rated them. People who rated two or more of the 17 drugs. Shaded bands are 95% intervals from resampling people.

People who panicked on more than half their trips with one drug panicked on 28% of trips with their other drugs; people who never panicked on that drug, on 13%, against an average of about 17% for those drugs. Regret works the same way (27% against 15%); pleasure less so (74% against 67%). So a bad run with one drug is a modest warning sign for others, panic most of all; the rest is the pairing, noise, or things the survey didn't ask about, such as dose and setting.

5. Who does better on what

Figure 6 compares groups on panic and regret, averaged over the 13 drugs with 180 or more raters, with the drug, number of uses, age and sex held constant.

Dot plot of adjusted differences in percentage points. Trips with panic or acute anxiety: anxiety as a listed condition +5.3, social anxiety +5.0, substance abuse disorder +4.9, age 14-24 vs 45 and over +4.6, agree I worry about things +4.6, PTSD or C-PTSD +4.4, disagree I'm mentally well +4.1, agree if life is a game then I'm losing +3.8, cis women vs cis men +3.2, depression +2.7, agree supernatural is plausible +2.1, trans or nonbinary vs cis men +0.9 and ADHD +0.9 (not distinguishable from zero), left vs right of centre -2.3. Uses they'd go back and stop: substance abuse disorder +5.7, PTSD +3.9, losing +3.9, cis women +3.7, not mentally well +3.5, worry +2.4, supernatural +2.4, anxiety +2.3, left vs right -4.7; social anxiety, depression, age, ADHD and trans or nonbinary not distinguishable from zero.
Figure 6. Difference between each group and its comparison group, in percentage points of trips or uses, averaged over 13 drugs, with the drug, number of uses (separately for each drug), age and sex held constant. Grey: not distinguishable from zero after a correction for the 45 comparisons. Conditions are from "Do you have any of the following", where people could tick any that applied. Bars are 95% intervals. 3,399 people.

The same kinds of people report more panic across their drugs. People who agree "I worry about things." report panic on 18% of their trips on average, against 13% for those who disagree; the gap is more than a point on 10 of the 13 drugs, with none for salvia or nitrous and a slight reversal for 2C-B. People who ticked anxiety as a condition report panic on 22% of trips against 15% (higher on all 13 drugs), and so do people with PTSD or C-PTSD and people with social anxiety (22% against 16% each). Panic is also higher for 14 to 24-year-olds (20%, against 13% at 45 and over) and cis women (20%, against 16% for cis men).

Regret follows some of the same lines: 24% of uses for people with a substance abuse disorder against 18%, 23% against 17% for PTSD, 22% against 16.5% for people who disagree "I'm mentally well". Right-of-centre people would take back more of their uses than left-of-centre people (22% against 17%), but this is mixed by drug: about 10 to 12 points more for GHB, alcohol and marijuana and 9 for nitrous, near zero or reversed for ketamine, psilocybin, LSD and DXM. Cis women report fewer pleasurable trips than cis men (68% against 72%), lower on all 13 drugs.

Few matches between particular kinds of people and particular drugs were detectable. We tested whether each of 25 traits (demographics, personality, wellbeing, beliefs and mental health conditions) went with panic, regret, pleasure or impact on life differently for each of the 13 drugs: 1,300 combinations. A drug-specific difference had to pass a correction for all 1,300 tests and show up in each of two random halves of the sample, a high bar for drugs with 170 to 400 raters, so modest real matches could easily be missed. Nine passed:

Drug and answerGroupsRaters of this drugOn this drugOn their other drugs
Marijuana: uses they'd take backPTSD or C-PTSD, yes / no244 / 1,56826% / 28%19% / 14%
Marijuana: uses they'd take backRight / left of centre350 / 1,22435% / 25%16% / 15%
Marijuana: trips with panicAge 25+: no bachelor's degree / bachelor's or higher376 / 1,08529% / 22%16% / 14%
Marijuana: impact on life (−3 to +3)Conscientiousness items: lower / higher scorers687 / 611+0.08 / +0.41+0.68 / +0.79
Salvia: trips with panicADHD, yes / no129 / 17436% / 27%15% / 17%
2C-B: trips significantly pleasurableAge 35+ / 14–24142 / 4471% / 86%71% / 77%
Alcohol: uses they'd take backAge 35+ / 14–24274 / 20841% / 25%18% / 19%
Alcohol: impact on life (−3 to +3)Supernatural plausible, agree / disagree345 / 380−0.52 / −0.25+0.86 / +0.69
Alcohol: impact on life (−3 to +3)Agreeableness items: higher / lower scorers193 / 326−0.73 / −0.30+0.97 / +0.68

Each cell gives the first group, then the second. "On their other drugs" is the same people's average over the other drugs they rated, among the 13. "Lower" and "higher scorers" are the bottom 38% and top 33% of people on the two conscientiousness items, and the bottom 42% and top 21% on the two agreeableness items (the scores are too coarse for equal thirds). Answers are percentages of trips or uses, except impact on life (−3 to +3).

Four are about marijuana and three about alcohol. The right-versus-left marijuana gap is about as large for alcohol and GHB, so it is less specific to marijuana than it looks. Older drinkers' higher regret may partly reflect drinking more, since the use question tops out at "1000+". The 2C-B row has only 44 people in the younger group.

6. Ways of relating to drugs

Some questions are about how people use and see a drug rather than the experience. To get at a person's style rather than their choice of drugs, each answer is compared with other users of the same drug and averaged over the person's drugs, for the 2,449 people who rated two or more of the 17 drugs. About half the approval and concern answers were "There's been no change"; those count as missing.

Correlation heatmap of eleven person-level answers. Good while partying, to enhance sex, for physical skill and at work correlate 0.21 to 0.40 with each other and 0.14 to 0.24 with times used. Integration period and made me more spiritual correlate 0.43, and others approved of changes correlates 0.21 and 0.25 with them. Uses they'd take back and others expressed concern correlate 0.27. Uses they'd take back correlates -0.21 with good while partying. Research before first use correlates 0.15 or less with everything.
Figure 7. Correlations between people's average answers across the drugs they rated, after comparing each answer with other users of the same drug. 2,449 people who rated two or more of the 17 drugs. Approval and concern use only ratings where people said their use had changed them, so their cells rest on fewer people: 1,710 with an approval score, 1,791 with a concern score, 1,565 with both.

There are three loose styles, not one general enthusiasm. One is fun and function: rating your drugs as good for partying, sex, physical activity and work, and using them more often. A second is meaning: an integration period and becoming more spiritual, with others' approval going along more weakly (0.21 and 0.25). A third is regret: taking back more of your uses, and others expressing concern. Research stands mostly apart. Fun and meaning correlate 0.24; regret is slightly negative with fun (−0.11) and unrelated to meaning (0.00). Sorting people into clusters gives only weak separation, so these are tendencies, not camps.

Agreeing with "I find the existence of the supernatural to be plausible" goes with the meaning style more than anything else measured (0.27 standard deviations per standard deviation); the survey can't say which comes first. Openness and wellbeing go with meaning more weakly (0.13 each), extraversion with fun (0.11), and having ticked any listed mental health condition with regret (0.18). Younger people report more research before first use (0.19 standard deviations per decade), and cis women less than cis men (0.19).

7. How intense does it get?

Two questions asked about intensity: "On average, most of the time you've done [drug], how intense is this drug for you?" and "How strong was your strongest experience on [drug]?". Both were answered from 0 to 5 in half points, with these labels on the whole numbers:

Dot plot of the share whose strongest experience was 5. All users: salvia 49%, DMT 47%, 5-MeO-DMT 44%, ayahuasca 36%, alcohol 31%, ketamine 22%, nitrous oxide 22%, DXM 14%, LSD 13%, psilocybin 12%, GHB 11%, marijuana 7%, mescaline 5%, MDMA 4%, 2C-B 3%, ecstasy 3%, MDA 3%. Among people who used it 4 to 8 times: salvia 58%, DMT 49%, ayahuasca 38%, ketamine 23%, nitrous oxide 20%, DXM 20%, psilocybin 12%, LSD 11%, alcohol 9%, GHB 7%, marijuana 7%, mescaline 3%, 2C-B 2%, MDMA 2%, ecstasy 1%.
Figure 8. Share whose strongest experience on each drug was 5. Filled: all users. Open: people who had used it 4 to 8 times (answer ranges "4-5" and "6-8"), shown where 20 or more people. 10,836 ratings by 3,223 people. Bars are 95% intervals.

How rare a 5 is depends more on the drug than on the person, and strongly on how many times someone has used it. About half of salvia (49%) and DMT (47%) users put their strongest experience at 5, and 44% of 5-MeO-DMT and 36% of ayahuasca users. For ketamine and nitrous it's 22%, LSD and psilocybin 12 to 13%, marijuana 7%, and MDMA, ecstasy, MDA and 2C-B 3 to 4%. Split as in section 4, which drug it was goes with 18% of the variation and who was answering with 9%; most goes with neither. Alcohol is the outlier: its typical intensity is low (a median of 1.5), but 31% of drinkers rate their strongest experience a 5, almost all of them heavy drinkers. Among people who have drunk 50 times or fewer it's 10%; among those with more, 35%, about the same as psilocybin users with more than 50 uses (36%).

By kind of drug, counting each person once per group, 5s are most common for salvia (49%) and the DMT family (45%), then alcohol and GHB (28%) and the dissociatives (ketamine, nitrous, DXM; 25%), then the classic psychedelics (16%), marijuana (7%) and MDMA, ecstasy and MDA (4%).

Line chart of the share whose strongest experience was 5, by number of times used. Salvia: 31% after one use, 50% at 2-3, 58% at 4-8, 72% at 9-20. DMT: 30%, 47%, 49%, 58%. Ketamine: 2%, 9%, 23%, 23%, 32%, 56% at 51 or more. Nitrous oxide: 3%, 8%, 20%, 20%, 35%, 46%. Psilocybin: 4%, 6%, 12%, 12%, 19%, 36%. Alcohol: 2% at 9-20, 19% at 21-50, 35% at 51 or more. LSD: 2%, 9%, 11%, 20%, 18%, 28%. MDMA: 2%, 3%, 2%, 5%, 7%, 9%.
Figure 9. Share whose strongest experience was 5, by how many times they had used the drug (groups of 25 or more people). Shaded bands are 95% intervals.

More uses mean more chances for a big experience (and perhaps a higher dose): for ketamine, 2% of one-time users and 56% of people with more than 50 uses have had a 5; for alcohol, 2% of people who have drunk 9 to 20 times and 35% of those with more than 50 occasions. Apart from alcohol, the drugs keep roughly their order at the same number of uses: among people with 4 to 8 uses, 58% of salvia and 49% of DMT users had had a 5, against 12% for psilocybin, 11% for LSD and 2% for MDMA.

Among the 1,704 people who rated every drug they had ticked, 33% have had a 5 on a drug other than alcohol (69% at least a 4), rising from 16% of people who rated two such drugs to 70% of those who rated eight or more. Among the 722 of them who could also report alcohol, 45% have had a 5 on something.

Class. For drug class, see the grouping above. For social class, the survey has no income or class question; education is the nearest proxy, and among people 25 and over 15 to 17% of ratings at each education level are 5s (adjusted differences within 1.2 points).

Where do you fall? The table gives each drug's typical answers and the share of users at or above each strongest-experience level. If your strongest psilocybin trip was a 4, you're among the 37% of psilocybin users who rated theirs 4 or higher; a 5 puts you among the top 12%.

DrugUsersTypical intensity (median)Strongest (median)Strongest 3 or moreStrongest 4 or moreStrongest 5
Salvia31544.578%69%49%43–54%
DMT39344.585%78%47%42–52%
5-MeO-DMT11044.581%69%44%35–53%
Ayahuasca1183.5483%71%36%28–45%
Alcohol8621.5478%61%31%28–34%
Ketamine6932467%52%22%19–26%
Nitrous oxide6693468%55%22%19–26%
DXM1802.5367%42%14%10–20%
LSD1,35723.565%40%13%12–15%
Psilocybin1,5882360%37%12%11–14%
GHB17322.547%32%11%7–17%
Marijuana1,9401.5363%40%7%6–8%
Mescaline15322.543%20%5%2–9%
MDMA97822.540%18%4%3–5%
2C-B3702232%13%3%2–6%
Ecstasy82522.541%18%3%2–4%
MDA1122233%14%3%1–8%

Users who answered the strongest-experience question. Medians are on the 0 to 5 scale. The last column has a 95% interval below each number. Drugs are sorted by the share at 5.

8. Could it be something else?

Isn't the person effect just how people use the sliders? If some people simply gave bigger numbers to every percentage question, the people who report more panic would also report more pleasurable trips. Instead, people's tendencies to report panic and pleasure across their drugs correlate −0.35, and regret and pleasure −0.38. That rules out a plain big-numbers habit, but not a general tendency to describe things negatively, which would produce the same pattern.

Isn't it just how often people used each drug? Holding the number of uses constant leaves the person shares almost unchanged (16% for panic, 18% for regret). Uses matter a lot for 5s, which is why Figures 8 and 9 show them.

Aren't these just the people who kept going? Partly. People who had a bad time may have stopped after a try or two, and enthusiasts are likelier to take a long drug survey. These are people's own accounts of drugs they chose, often years later, not measured effects.

Methods and limits

Data. Drug Experiences survey, October 2024 to January 2025, with the same cleaning as The Drug Report Card. People answered the same block of 31 questions for each drug they ticked, in random order, so people who dropped out partway answered a random subset of their drugs; person-level summaries weight people, not ratings.

StepDroppedLeft
Runs in the export5,329
Didn't reach the first drug checklist1,6653,664
Developer test runs53,659
Gave the same answer to every statement for every drug they rated293,630
Finished in under 1.75 minutes per rated drug (this leaves the cleaned sample)143,616
Didn't answer the second checklist253,591
Ticked no listed drug other than alcohol (98 ticked nothing, 51 only alcohol)1493,442

Table. The 3,442 people in the last row are the portfolio sample (sections 1 and 2). The drug ratings (sections 3 to 7) come from the 3,616 people in the cleaned sample: after dropping ratings of drugs used zero times, 3,430 rated at least one of the 17 drugs with 100 or more raters, giving 11,445 ratings; 2,449 rated two or more.

Ages and scales. People under 18 are included as one more age band (36 aged 14 to 17 in the portfolio sample, 39 among raters; ages 14 to 81). Education comparisons use people 25 and over. Agreement statements used a 4-point scale for 92% of ratings; early 7-point answers were mapped onto it, with strongly disagree to neutral counted as disagree. Alcohol was on the checklist only from about five days into the run, so it is left out of the portfolios and of the 33% figure for person-level 5s; the 45% figure counts it only for the 722 people who could tick it. The survey spells ayahuasca "Ayahuascha".

Models. Portfolios: latent class models on the 25 drugs tried by at least 2% (alcohol excluded); six classes fit very slightly better by BIC but replicated worse in random halves (adjusted Rand index 0.46 to 0.77, against 0.57 to 0.73 for five), and with five a sixth to a third of people changed type between halves. A tetrachoric factor analysis found one dominant factor (first eigenvalue 10.7, then 1.2). Experiences: factor analysis (minres, oblimin) of polychoric correlations of the 26 answers; five factors kept (59% of the variance; split-half congruence 0.94 or more; a general factor, omega hierarchical 0.67, is essentially the spiritual dimension). Types are k-means clusters of the five scores (silhouette about 0.2, weak structure). Person or drug: mixed models with crossed random intercepts for person and drug, intervals from 60 resamples of people. Who does better: mixed models with a person intercept, a separate intercept and log-uses slope per drug, age, sex, and a trait slope per drug; a drug-specific difference (a drug's slope minus the average across the 13) needed a Benjamini-Hochberg q below 0.05 across 1,300 tests and the same sign with one-sided p below 0.05 in each random half. Styles: answers standardized within drug, averaged within person, factor-analysed (three factors; reliabilities 0.40 to 0.62, so rough measures).

Limits. Mostly experienced, left-leaning cis men who follow Aella, not all drug users. Each rating sums up all of someone's uses of a drug, with no dose, setting or single occasions. The trip questions say "trips" even for alcohol, marijuana and nitrous. The checklists record only whether people had ever done each drug, so nothing here shows which drug led to which.

Process. This analysis was done with AI assistance.